BiotechTube
TBD Pharmatech

TBD Pharmatech

Vienna, Europe - Other· Est.
tbdpharmatech.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

TBD Pharmatech is a European CDMO focused on the development and GMP manufacturing of small-molecule APIs for pharmaceutical and biotech clients. Founded in 2008, it has established a dual-site operational model in Tartu, Estonia, offering a full spectrum of services from R&D to commercial production and distribution under EU-GMP, ISO 9001, and GDP standards. The company positions itself as a reliable, EU-based partner for complex, niche-to-mid-volume API projects, emphasizing technical depth, regulatory integration, and supply chain security for its global customer base.

Drug DeliverySmall Molecules

Technology Platform

Integrated small-molecule API development and GMP manufacturing platform utilizing a dual-site model (R&D and commercial production) under a unified EU-GMP, ISO 9001, and GDP quality system.

Opportunities

Growing demand for niche, complex API manufacturing for targeted therapies and the industry's push for EU-based supply chain resilience present significant opportunities.
The integrated 'development-to-commercial' service model is highly attractive to virtual and small biotech companies.

Risk Factors

Key risks include client concentration, intense competition in the CDMO sector, and operational/regulatory risks where any quality failure or inspection citation could severely damage its reputation as a reliable GMP partner.

Competitive Landscape

Operates in the competitive European small-molecule API CDMO space, competing against larger global players and other niche specialists. It differentiates through a focused niche-to-mid-volume strategy, integrated regulatory services, and its positioning as a secure, dual-site EU manufacturer.

More companies in Small Molecule Drugs →More companies in Europe - Other →